Bovine Pili Shield+CThis page contains information on Bovine Pili Shield+C for veterinary use.
The information provided typically includes the following:
- Bovine Pili Shield+C Indications
- Warnings and cautions for Bovine Pili Shield+C
- Direction and dosage information for Bovine Pili Shield+C
Bovine Pili Shield+CThis treatment applies to the following species:
Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid
For Use In Animals Only
Bovine Pili Shield+C Indications
For use in healthy pregnant cattle as an aid in the prevention of enterotoxemia in calves caused by Clostridium perfringens Type C and colibacillosis in calves caused by K99 piliated Escherichia coli.
ADJUVANT: Xtend® III.
Directions For Use
Shake well before using. Administer 1 mL intramuscularly in the neck 8-16 weeks prior to calving. Vaccinate dairy cows at dry-off. Revaccinate prior to each subsequent calving.
PrecautionsStore out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. It is essential that newborn calves receive colostrum from the vaccinated dam. WARNING: THIS PRODUCT MAY CAUSE PERSISTENT SWELLING AT THE SITE OF INJECTION. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains thimerosal as a preservative.
U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2007 Novartis; Pili Shield and Xtend are registered trademarks of Novartis AG
NAC No.: 11140065
Farm Animal Business
1447 140TH ST., LARCHWOOD, IA, 51241
|Every effort has been made to ensure the accuracy of the Bovine Pili Shield+C information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2015 North American Compendiums. Updated: 2015-04-03